4//SEC Filing
Taylor Stacy L 4
Accession 0001209191-22-017397
CIK 0001478320other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 9:00 PM ET
Size
9.1 KB
Accession
0001209191-22-017397
Insider Transaction Report
Form 4
Taylor Stacy L
SVP and General Counsel
Transactions
- Award
Common Stock
2022-03-04+61,779→ 76,815 total - Sale
Common Stock
2022-03-07$12.01/sh−1,569$18,844→ 75,246 total - Award
Stock Option (Right to Buy)
2022-03-04+154,448→ 154,448 totalExercise: $12.14Exp: 2032-03-04→ Common Stock (154,448 underlying)
Footnotes (2)
- [F1]This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]The options vest with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
Documents
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001799081
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 9:00 PM ET
- Size
- 9.1 KB